|
LEI Number: 213800VFRMBRTSZ3SJ06
|
|
1st August 2024
CHESNARA plc
("Chesnara", "the Company" or the "Group")
NOTIFICATION OF PDMR DEALING AND TOTAL VOTING RIGHTS
Chesnara (CSN.L), the European life insurance consolidator, today announces that PDMR Steve Murray has exercised options over 33,625 ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares") as a result of the vesting of the awards made under the 2014 Chesnara Long Term Incentive Plan. Of these, 16,482 Ordinary Shares were sold to cover liability to tax and national insurance contributions arising on vesting, with the balance being retained. The allotment of the 33,625 Ordinary Shares has been satisfied via the Group's existing block listing arrangements.
Further, in conformity with 5.6.1 of the Disclosure Guidance and Transparency Rules, as at the date of this announcement and following the exercise of options noted above, the Company's issued share capital consisted of 150,991,019 Ordinary Shares and, with no Ordinary Shares in Treasury, this too was the number of voting rights.
This figure of 150,991,019 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Steve Murray |
| 2 | Reason for the notification | |
| a) | Position/status | Group Chief Executive Officer (and PDMR) |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Chesnara plc |
| b) | LEI | 213800VFRMBRTSZ3SJ06 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Chesnara plc Ordinary shares of 5 pence each (Shares) ID Code: (GB00B00FPT80) |
| b) | Nature of the transaction
| 1. Exercise of options over 33,625 shares following vesting of the conditional awards under the 2014 Long Term Incentive Plan. 2. 16,482 shares sold to cover tax and social security obligations. |
| c) | Price(s) and volume(s) | 1. Price(s): nil. Volume: 33,625. 2. Price(s): 255.875p. Volume: 16,482. |
| d) | Aggregated information | N/A |
| e) | Date of the transaction | 1. 31st July 2024 2. 31st July 2024 |
| f) | Place of the transaction | 1. XOFF 2. XOFF |
For further information, please contact:
Investor Enquiries
Sam Perowne
Head of Strategic Development & Investor Relations
Chesnara plc
E - sam.perowne@chesnara.co.uk
Media Enquiries
Roddy Watt
Director, Capital Markets
FWD
T - 020 7280 0651 / 07714 770 493
E - roddy.watt@fwdconsulting.co.uk
Notes to Editors
Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.
Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden, the Netherlands and the UK and by undertaking value-adding acquisitions of either companies or portfolios.
Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 19 years in succession.
Further details are available on the Company's website (www.chesnara.co.uk).
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.